z-logo
Premium
Comparative survey of the topographical distribution of signature molecular lesions in major neurodegenerative diseases
Author(s) -
Arnold Steven E.,
Toledo Jon B.,
Appleby Dina H.,
Xie Sharon X.,
Wang LiSan,
Baek Young,
Wolk David A.,
Lee Edward B.,
Miller Bruce L.,
Lee Virginia M.Y.,
Trojanowski John Q.
Publication year - 2013
Publication title -
journal of comparative neurology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.855
H-Index - 209
eISSN - 1096-9861
pISSN - 0021-9967
DOI - 10.1002/cne.23430
Subject(s) - biology , neuroscience , signature (topology) , distribution (mathematics) , mathematics , mathematical analysis , geometry
An understanding of the anatomic distributions of major neurodegenerative disease lesions is important to appreciate the differential clinical profiles of these disorders and to serve as neuropathological standards for emerging molecular neuroimaging methods. To address these issues, here we present a comparative survey of the topographical distribution of the defining molecular neuropathological lesions among 10 neurodegenerative diseases from a large and uniformly assessed brain collection. Ratings of pathological severity in 16 brain regions from 671 cases with diverse neurodegenerative diseases are summarized and analyzed. These include: 1) amyloid‐β and tau lesions in Alzheimer's disease; 2) tau lesions in three other tauopathies including Pick's disease, progressive supranuclear palsy and corticobasal degeneration; 3) α‐synuclein inclusion ratings in four synucleinopathies including Parkinson's disease, Parkinson's disease with dementia, dementia with Lewy bodies, and multiple system atrophy; and 4) TDP‐43 lesions in two TDP‐43 proteinopathies, including frontotemporal lobar degeneration associated with TDP‐43 and amyotrophic lateral sclerosis. The data presented graphically and topographically confirm and extend previous pathological anatomic descriptions and statistical comparisons highlight the lesion distributions that either overlap or distinguish the diseases in each molecular disease category. J. Comp. Neurol. 521:4339–4355, 2013. © 2013 Wiley Periodicals, Inc.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here